Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Deutsche Bank Raises Price Target on Illumina (ILMN), Maintains Buy Rating
-
Deutsche Bank Reiterates a 'Buy' on Illumina (ILMN); Momentum in Sequencing Demand Remains Unabated
-
Deutsche Bank Upgraded the Life Science Tools Sector to Outperform (TMO, LIFE, ILMN)
-
Illumina (ILMN): Defended following a negative pre-announcement
-
Deutsche Bank Reiterates a 'Buy' on Illumina (ILMN), Raises Price Target & 2011 Estimates
-
Deutsche Bank Reiterates a 'Buy' on Illumina (ILMN); Raises Price Target
-
Deutsche Bank Reiterates a 'Buy' Rating on Illumina (ILMN), Valuation Still Highly Attractive
-
David Moenning's Daily State of the Markets: 7/23
-
David Moenning's Daily State of the Markets: 1/11
-
Deutsche Bank Upgrades Affymetrix (AFFX) to Buy
